Global Cardiovascular Devices Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Cardiovascular devices are the medical devices used to treat cardiovascular diseases and to monitor the cardiovascular system. These devices are used to stop the bleeding (hemostasis) of the small hole in the artery after a cardiovascular procedure. Arrhythmia, congestive heart failure, and ischemic stroke are the major cardiovascular diseases, usually characterised by the abnormal rhythm of the heart. To overcome all these problems cardiovascular devices are implemented to diagnose diseases. Cardiovascular procedures require catheterisation, where the catheters are inserted into the body to perform operations during the surgical procedures.

Global Cardiovascular Devices Market Segments Size & Growth:

Cardiovascular devices market is projected to reach approximately USD 73.29 Billion by 2024, at a CAGR of 6.9% from XX Billion in 2017 during the forecast period. The key attributes promoting the cardiovascular devices market growth are growing geriatric population, high preference of minimally invasive procedures, and rising prevalence of cardiovascular disease. Technical innovations and advancements in the cardiovascular devices have made a major impact on the global cardiovascular devices market. Cardiovascular disease is the major cause of all the deaths. To reduce the time to hemostasis, to enable early ambulation, and to improve patient comfort these medical devices are implemented. Cardiac monitoring refers to the continuous monitoring of the heart activity and has to make an assessment relative to the patient’s cardiac rhythm. It generally includes electrocardiography.

By considering the reports of World Health Organization 19 Million people across the globe are died in 2012, due to CVD (Cardiovascular Disease), and around 21 Million people are estimated to die by 2024. In United States region nearly 65% of the people aged above 65 years are having the CVD problem. Growing prevalence of cardiovascular diseases, augmenting geriatric population, and obese population is also the factors contributing to the cardiovascular diagnostic and monitoring devices market, which holds the largest market share across the globe.

Global Cardiovascular Devices Market Segments Share:

Global Cardiovascular Devices Market is segmented by product type which comprises of Cardiac Rhythm Management (CRM), Cardiac Monitoring Devices, Cardiac Surgery Devices, interventional cardiology, peripheral vascular devices, plaque modification devices, and flow alteration devices. External defibrillators can be used as emergency life-saving, with the advent of the sudden heart attack. Rising incidence of sudden heart attacks is propelling the market growth for CRM devices in the United States. Due to saturation of pacemaker’s implementation will witness a slight decline in the overall CRM devices market share.

By procedure, the market is segmented into minimally invasive heart surgery, open heart surgery, heart valve repair or replacement, and angioplasty. From technology, the market is further classified into cardiopulmonary bypass products, bioresorbable stents, and cardiac assist devices.

By end-users and applications, the market is further divided into segments. By application cardiac arrhythmia held the highest market share owing to the high prevalence of cardiac arrhythmia. By Geography, North America holds the largest market share and shows the dominance of the overall cardiovascular devices market, due to high implementation and high adoption rate for advanced surgical treatments and presence of a large size target patient pool. Asia Pacific region is witnessed as the fastest growing region in cardiovascular devices market, owing to the rise in awareness level, and growing geriatric population.

Global Cardiovascular Devices Market Trends:

• GE Healthcare recently launched Computed Tomography for Vascular to provide the clinical data needed for a confident diagnosis, and to boost up the study analysis fast and efficient.
• Johnson & Johnson is one of the top players in cardiovascular devices market announces that Biosense Webster, Inc wanted to develop innovative technologies, which can improve the quality of care for arrhythmia patients.
• Siemens Healthcare Company is one of the top players in cardiovascular devices market launched Stratus CS Systems at the point of care to improve patient outcomes, staff efficiency, and to take or enable rapid decision making for the patient care.

Global Cardiovascular Devices Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with major competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The major key players in the Global Cardiovascular Devices Market are:

• Medtronic
• Boston Scientific Corporation
• LivaNova PLC
• Abbott Laboratories
• Johnson & Johnson
• GE Healthcare

Along with these companies, there were many other companies considered/cited in the report while analysing the  Global Cardiovascular Devices market. These companies hold substantial share-owning to the nature of the industry whereas rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.